Hemorrohiod. Unspecified haemorrhoids with other complications
Conditions
Interventions
Intervention 1: Intervention: Topical use of thin-layer Hemoheal cream twice a day for a month. Intervention 2: Control: Topical use of thin-layer eucerin base cream twice a day for a month.
Treatment - Drugs
Placebo
Intervention: Topical use of thin-layer Hemoheal cream twice a day for a month
Control: Topical use of thin-layer eucerin base cream twice a day for a month
Sponsors
Vice Chancellor for Research, Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age>18 Patients who sign the testimonials and cooperate during the study Patients who their diseases are confirmed by complete medical evaluation including colonoscopy, pathology and laboratory data Only patients with mild to moderate hemorrhoids can be included in this study Patients who were not cured with Hemoheal cream during the last month
Exclusion criteria
Exclusion criteria: 4th-degree hemorrhoids Pregnant patients and nursing mothers Patients who have to use other drugs that interference with this medication Previous history of anorectal surgery Patients who are suffering from other diseases in addition to hemorrhoids, such as apparent coagulation abnormalities or kidney impairment accompanied with colorectal diseases such as cancer, Crohn's disease, ulcerative colitis, anal fistula, anal fissure, proctitis or perineal skin inflammation Patients who are disposed to a serious health danger, such as severe cardiac, liver or renal diseases If significant side effects occur, the patient will be excluded from the study and followed to end of the study Patients with severe allergy to this plant (dermatitis contact)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of excretion daily. Timepoint: Before using the drug; 2 weeks after using the drug-30 days after using the drugs. Method of measurement: Based on Hemorrohiod clinic questionary.;Rate of rectal bleeding. Timepoint: before using the drug; 2 weeks after using the drug-30 days after using the drugs. Method of measurement: based on Hemorrohiod clinic score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Gastrointestinal disorders. Timepoint: Two weeks after using the drug; 30 days after using the drug. Method of measurement: Based on side effect questionary. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFateme Parvizi
Kermanshah University of Medical Sciences
Outcome results
None listed